This Technology Has Ended All Pandemics — Forever

While vaccine debates make for great political fodder, the bottom line is that most of us are alive today because of vaccines. And in the case of messenger RNA vaccines, this is just the next evolution of vaccine science — and an amazing opportunity for investors to make a lot of money. While vaccine debates make for great political fodder, the bottom line is that most of us are alive today because of vaccines. And in the case of messenger RNA vaccines, this is just the next evolution of vaccine science — and an amazing opportunity for investors to make a lot of money. [Wealth Daily logo] This Technology Has Ended All Pandemics — Forever [Jeff Siegel Photo] By [Jeff Siegel]( Written May 18, 2021 There was an interesting piece in Reason magazine recently titled, "Why COVID-19 May Be the Last Pandemic.” The argument is that medical breakthroughs in the world of biotech — such as “messenger RNA” vaccines — will result in the global community never having to suffer from diseases like COVID-19 again. Reason science correspondent Ronald Bailey writes: The horrors of the last year have spurred humanity to quickly develop an unprecedentedly flexible and powerful tool kit that may well make COVID-19 the last true pandemic. Now you can just slip any piece of genetic information into [a] lipid and... you have a vaccine. While I know vaccine debates make for great political fodder, the bottom line is that most of us are alive today because of vaccines. And in the case of messenger RNA vaccines, this is just the next evolution of vaccine science — and an amazing opportunity for investors to make a lot of money. The Best Trade Opportunity in a Decade No, it isn’t GameStop, AMC, or any of those other meme stocks. According to Keith Kohl, this $1.1 trillion sector is the best place for traders looking to make money. [Click here to see the details.]( A 1,438% Gain in Less Than Two Years One of the biggest winners in the race for a COVID-19 vaccination was BioNTech (NASDAQ: BNTX). BioNTech is a German player that was specializing in messenger RNA before the pandemic hit us with all the subtlety of a brick to the face. It was actually one of the biggest biotech listings of all time when it went public, with a valuation of $3.4 billion. Still, despite the enthusiasm over the stock, you could’ve bought shares of this thing for as little as $16 a share. Pretty cheap considering the company was a leader in this new messenger RNA technology. And of course, after the company inked a deal with Pfizer and began developing a vaccine for COVID-19, the stock skyrocketed to more than $200 a share. [bntx11] That’s a 1,438% gain in less than two years. That, my friend, is how biotech billionaires are created. Did This $3 Firm Just Make Tesla Obsolete? There will be 12 million electric cars on the road in five years. And believe it or not, [THIS]( strange liquid could power every single one. [gcs nene liquid]( Don't believe it? See the proof for yourself... [Click here.]( Of course, not every biotech play is going to pay off like BNTX. Truth is, most investors just don’t have access to the kind of intel that can tip you off to a $13 stock that’ll soon be worth $200. Just like anything, it’s all about access. Like George Carlin said, “It’s a big club, and you ain’t in it.” But you don’t have to be in the club to get access to this kind of intel. You just need access to someone who does. And this week, we’re going to introduce you to that person. Moreover, we’re going to show you how to use his access to the world of biotech billionaires so you can get some of this action for yourself in a special webinar you’ll be able to attend absolutely free. Just [click here now]( to lock in your spot, as spaces are limited. I’ll certainly be there, and I look forward to seeing you there too. To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]@JeffSiegel on Twitter]( --------------------------------------------------------------- World War II Technology Is Still Saving Lives Thanks to COVID-19 vaccines, we are finally starting to see relaxed regulations in the United States. But that doesn’t mean precautions are no longer needed. The unvaccinated are still at risk. Hospitals in India have been overrun, with the country reporting just below 400,000 COVID-19 infections per day this past week. Not to mention coronavirus mutations continue popping up worldwide. And while scientists are hopeful… they still aren’t 100% certain that our vaccines will protect us against fast-spreading mutations. Luckily, there’s a technology that can protect us as we get back to “normal” life. This “Invisible Detection” technology is about to be installed in every public area to detect and isolate those with symptoms and ultimately prevent outbreaks of COVID-19. And the best part is that we already know this technology works. It saved lives and made companies millions when we first used it back in World War II. In fact, those World War II investors saw massive gains like 21,608%. I’m fully expecting those kinds of gains over the next few years… and up to 1,500% just in the next few months! That’s enough to turn a $10,000 investment into $150,000. Companies worth over $7 trillion are lining up for this tiny company’s technology, and it won’t be trading for under $1 for long. See this for yourself. [Click here for details.]( Browse Our Archives [How to Win the Numbers Game]( [The EV Industry's Dirty Secret]( [What Might the Future of Biotech Look Like?]( [The ESG Mirage]( [They Turned Sunlight and Water Into Green Fuel]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.